Pharma & Biotech

Biopharmaceutical firm Denali Therapeutics finds itself navigating a turbulent period in the markets. Despite reporting significant progress in its clinical...

The curtain has fallen on Walgreens Boots Alliance's tenure as a publicly traded entity. Private equity firm Sycamore Partners has...

Replimune Group Inc. finds itself navigating turbulent market conditions as its stock value experiences a dramatic collapse. The biotechnology firm...

Investors in Liquidia Corporation are bracing for a pivotal moment as the biotechnology company prepares to unveil significant clinical trial...

Investors showed renewed confidence in Capricor Therapeutics last week following a significant regulatory development from the U.S. Food and Drug...

A recent analyst report dated September 29 has cast a favorable light on Aldeyra Therapeutics, identifying the biotechnology company as...

The biotechnology leader Amgen presents investors with a puzzling scenario. Despite announcing substantial capital investments and reporting robust quarterly earnings,...

The animal health sector leader Zoetis finds itself navigating turbulent market conditions, presenting investors with a perplexing scenario. While the...

Investors in Cellectar Biosciences are bracing for significant volatility as the company approaches two major developments that could dramatically influence...

The equity performance of Gilead Sciences has captured significant market attention, with its shares advancing more than 25% since the...